Hide filtersShow filters × Close Bryan, Garnier & Co acts as Joint Bookrunner to Azelio on its SEK 270 million Follow-on Offering Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Innovasjon on the sale of the company to Visolit Bryan, Garnier & Co acts as Co-manager to BioNTech on its USD511.5 million upsized Publicly-marketed Follow-on Offering Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to Carbios on its EUR 37 million upsized Follow-on Offering Bryan, Garnier & Co advises Prosoft on its combination with personnel service software provider Landwehr, which is backed by growth technology investor Lea Partners Bryan, Garnier & Co acts as Sole Global Coordinator on a EUR 7.3 million Rights Issue for medtech company Pixium Vision Bryan, Garnier & Co acts as Financial Advisor to Quilvest Capital Partners on its acquisition of Blue Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Korta on the sale of the company to Rapyd Bryan, Garnier & Co acts as Sole Financial Advisor to Societe Generale on its acquisition of Shine Bryan, Garnier & Co advises Cathay Capital on its investment in FuturMaster Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner on MedinCell’s Follow-on with top-tier European biotech specialists and institutional investors Bryan, Garnier & Co acts as Sole Advisor to ECIT on the acquisition of 80% of IT-Hantverkarna Sverige AB (part of Fortner)
